High price-to-sales Based on Big Data Analytics: Returns up to 295.79% in 1 Year

High price-to-sales

The Fundamental Package includes our algorithmic forecasts for stocks screened by fundamental criteria. Our algorithms help you find best opportunities for both long and short positions for the stocks within each fundamental screen. The stocks are selected according to five basic valuation categories:

  • P/E (price to earnings ratio)
  • PEG (price/earnings to growth ratio)
  • price-to-book ratio
  • price-to-sales ratio
  • short ratio

Package Name: Fundamental – High price-to-sales ratio Stocks
Recommended Positions: Long
Forecast Length: 1 Year (01/17/2017 – 01/17/2018)
I Know First Average: 59.48%
High price-to-sales

This Fundamental – High price-to-sales ratio Stocks Package forecast had correctly predicted 9 out of 10 stock movements. The top performing prediction from this package was IMMU with a return of 295.79%. PODD, and SRPT had notable returns of 67.42% and 61.70%. The package’s overall average return was 59.48%, providing investors with a 36.27% premium over the S&P 500’s return of 23.21% during the same period.

Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.